Using reverse transcription-PCR and molecular cloning, the complementary DNA sequence encoding preproinsulin-like growth factor I (IGF-I) of a teleost, the tilapia (Oreochromis mossambicus) was established from liver. At the amino acid level, tilapia IGF-I shows all residues necessary for the maintenance of tertiary structure and shares about 80% identity with IGF-I from other teleosts. The B and A domains of tilapia IGF-I show more than 90% homology to those of other teleosts and 86 -93% to those of human. However, in contrast to salmonids, the C domain of tilapia is truncated. Reverse transcription-PCR analysis followed by Southern blotting with an internal probe specific for tilapia IGF-I indicated a transcript in liver, pancreas, gut, kidney, head kidney, gill, ovary, testis, eye, and brain. In correlation, parenchymal cells were identified as likely local production sites by the use of immunohistochemistry. IGF-I immunoreactivity was confined to D cells in pancreatic islets, gastroentero-endocrine cells, cells of renal proximal tubules, interrenal cells of the head kidney, gill chondrocytes, chloride cells of the gill epithelium, granulosa cells in the ovary, spermatocytes and Sertoli cells in testis, and neurons in retina and brain. The local production of IGF-I in multiple organs of the tilapia indicates paracrine/autocrine actions of IGF-I involved in organ-specific functions. The results further demonstrate that the primary structure of IGF-I, especially in the B and A domains, is highly conserved during phylogeny. (Endocrinology 138: [3613][3614][3615][3616][3617][3618][3619] 1997) 
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Fish are the oldest living vertebrates; they evolved about 500 million yr ago (2) . Few IGF-I sequences have been obtained from bony fish, mainly from the small family of salmonids, i.e. Oncorhynchus kisutch (3, 4) , O. mykiss (5) , and O. tshawytschwa (6) . In contrast to most other bony fish, salmonids are tetraploid (7) . For this and several other reasons we studied the tilapia (Oreochromis mossambicus). Tilapia belongs to the order of perciformes, which is the most diversified of all bony fish orders as well as the largest order of vertebrates (8) . Because tilapia is a mouthbrooder, and thus all developmental stages can be easily obtained, it represents an excellent experimental animal for studies on regulation during early life (9) . Previously, the presence of radioimmunoassayable IGF-I in tilapia serum has been shown (10) . Furthermore, the gene sequence of GH (GH) has been obtained from Tilapia nilotica (11) , and the GH-IGF-I axis probably plays an important role in development of fish (12) (13) (14) (15) . Finally, O. mossambicus is euryhaline, and GH might also be involved in its adaption to sea water (16) . Therefore, after clarification of essential parameters of the IGF-I system, tilapia may serve as a paradigm to study various IGF-I functions in fish.
In salmonids, IGF-I messenger RNA (mRNA) is expressed not only in liver (15) , but also at extrahepatic sites (4, (17) (18) (19) (20) . However, compared with mammals fewer organs have been identified to express IGF-I mRNA. Even less information is available on the presence of the IGF-I peptide. A distinct localization of IGF-I immunoreactivity has yet been given only for gastrointestinal tract and endocrine pancreas (21) (22) (23) . Thus, the likely cellular sites of IGF-I synthesis are generally unknown in bony fish. Hence, the present study on tilapia aims 1) to the establish the complementary DNA (cDNA) sequence of prepro-IGF-I, 2) to study the expression of IGF-I in various organs, and 3) to identify the likely sites of IGF-I production by the use of immunohistochemical methods.
Materials and Methods

Tissue preparation
Adult individuals of O. mossambicus were killed by a blow on the head (n ϭ 16 for molecular biology; n ϭ 7 for immunohistochemistry). Liver, pancreas, gut, head kidney, kidney, ovary, testis, gill, eye, and brain were rapidly dissected. Specimens for molecular biology were snapfrozen in liquid nitrogen and stored at Ϫ84 C until use. Specimens for immunohistochemistry were fixed by immersion in Zamboni fixative for 4 h at room temperature. After an overnight rinse in 70% ethanol, specimens were dehydrated in a graded ethanol series and routinely embedded in paraplast. Sections were cut at 4 m.
Reverse transcription-PCR (RT-PCR) for liver and sequence analysis
Total RNA was extracted from tilapia liver using the Ultraspec RNA Extraction Kit (ams, Lugano, Switzerland). The RNA concentration was determined by spectrophotometric absorption at 260 nm. For single stranded cDNA, 5 g total RNA were denatured for 3 min at 70 C and primed with a poly(deoxythymidine) 17 primer (5Ј-CCTGAATTCTA-GAGCTCAT(17)-3Ј; 30 pmol). For single stranded cDNA synthesis, the RNA-primer mix was incubated for 1 h at 37 C with 0.5 pmol/l deoxy-NTPs (Boehringer Mannheim, Mannheim, Germany), 1 ϫ reaction buffer (50 mm KCl, 1.5 mm MgCl 2 , 10 mm Tris-HCl), and 10 U AMV-reverse transcriptase (Appligene, Illkirch, France). RT-PCR was performed in a 50-l reaction volume [2 l cDNA, 1 ϫ reaction buffer, 200 m deoxy-NTPs, 1 m of each primer, and 1.2 U Taq DNA polymerase (Appligene)].
PCR products were purified using the Wizard PCR DNA Purification Kit (Promega, Madison, WI) and cloned applying the pCR-Script SK ϩ Cloning Kit (Stratagene, Heidelberg, Germany). For the sequencing reaction (Silver Sequence DNA sequencing system, Promega), plasmid DNA was purified using the Qiagen Plasmid Midi Kit (Qiagen, Basel, Switzerland). IGF-I expression was assessed with primers specific for O. kisutch IGF-I (3), i.e. IGF-IS1 (5Ј-AGAGAGGCTTTTATTTCAGT-3Ј) and IGF-IS2 (5Ј-ACTAACCTTGGGTG TTCCTTG-3Ј). Hot start, touch down RT-PCR was performed with 35 cycles of 1 min at 92 C, 2-min annealing (temperature decreasing from 50 to 40 C), and 3 min at 72 C, followed by two rounds of 3Ј-rapid amplification of cDNA ends. The first round was performed with 35 cycles of 1 min at 92 C, 2 min at 46 C, and 3 min at 72 C, using IGF-IS1 as gene-specific primer 1 and in an upstream direction the primer 5Ј-CCTGAATTCTAGAGCTCAT-3Ј (UDP) fitting on the restriction site of the poly(deoxythymidine) 15 primer. For the second round, 1 l of a dilution of 1:100 of the PCR product of the first round was used as template. Amplification was performed using the primers 5Ј-CAGGCTATGGCCCCAATGC-3Ј and UDP with 35 cycles of 1 min at 92 C, 2 min at 56 C, and 3 min at 72 C. The translated 5Ј-region was amplified using IGF-IS2 as the gene-specific antisense primer and the primer Pre-S TTTGTCGTGCGGAGACCCG in the 5Ј-untranslated region of salmon IGF-I (6) by RT-PCR with 35 cycles of 1 min at 92 C, 2 min at 53 C, and 3 min at 72 C.
Tissue expression
Total RNA of O. mossambicus organs was extracted, and first strand cDNA was synthesized as described above. The primers 5Ј-CAGGC-TATGGCCCCAATGC-3Ј and IGF-IS2 were used in a hot start, touch down PCR run with 35 cycles and decreasing annealing temperatures (55 to 45 C). The PCR products were separated on 2% agarose gel and stained with ethidium bromide. Southern blotting was performed on amplification products. DNA was transferred on positively charged nylon membrane (Boehringer Mannheim) overnight. The blot was prehybridized for 30 min in DIG EasyHyb (Boehringer Mannheim) and hybridized for 2 h at 68 C with the addition of 4 l digoxygenin (DIG)-labeled RNA probe. The DIG-labeled RNA probe spanned the region between the primers IGF-IS1 and IGF-IS2 of tilapia IGF-I and used the DIG RNA Labeling Kit (Boehringer Mannheim). The hybridized probe was detected with the DIG DNA detection kit (Boehringer Mannheim) and was visualized by chemiluminesence reaction on x-ray photographs.
Immunohistochemical protocol
To reduce unspecific binding, sections were treated with PBS containing 2% BSA and 2% normal goat serum and processed for immunofluorescence. Three antisera (K37, 116, and 118) raised in rabbits against human IGF-I were used diluted at 1:300 (22, 24) . Sections were incubated with one of the IGF-I antisera for 12 h at 4 C. After repetitive washing in PBS (pH 7.4), the primary antisera were detected using biotinylated goat antirabbit IgG (Bioscience Products, Emmenbrucke, Switzerland; 1:100) for 30 min at room temperature. Thereafter, sections were washed in PBS and incubated with streptavidin-fluorescein-isothiocyanate (FITC; Bioscience Products; 1:50) for 30 min at room temperature. For analysis of the coexistence of the classical islet hormones with IGF-I in the endocrine pancreas (24) and IGF-I and tyrosine hydroxylase (TH) in the head kidney (25) , single sections were incubated for double immunofluorescence. Rabbit IGF-I antisera and nonrabbit antisera against the islet hormones and TH were applied consecutively and detected by appropriate secondary antisera and labeling with FITC or Texas Red, respectively, as described previously (22) (23) (24) (25) .
Specificity controls
The specificity of the reactions obtained was tested using the following controls: 1) replacement of the primary antiserum by nonimmune serum, 2) preabsorption of the IGF-I antisera with recombinant human IGF-I, IGF-II, and bovine insulin (40 g; 400 g peptide/ml diluted antiserum). As positive controls, sections of rat pancreas (24) were processed. The different IGF-I antisera used probably reacted with identical cells as was found by analysis of consecutive sections. Preabsorption of the antisera with 40 g recombinant human IGF-I/ml completely blocked immunoreactions. IGF-I-immunoreactions were not affected by preabsorption with IGF-II and insulin at concentrations as high as 400 g/ml. Likewise, reactions obtained with the antisera against the islet hormones and TH were extinguished only by preabsorption with the corresponding antigen.
Photomicrographs were taken with a Zeiss Axiophot (Zeiss, Zurich, Switzerland). The fluorochromes were visualized with fluorescence modules for FITC and for Texas Red (24) .
Results
Sequence analysis
After amplification of the first strand cDNA of tilapia liver using the primers IGF-IS1 and IGF-IS2, a PCR product of about 240 bp was detected. Sequencing of the product and sequence analysis resulted in an unknown IGF-I gene sequence. The amplification and sequencing of the 3Ј-and 5Ј-ends of the translated IGF-I mRNA revealed a 543-bp DNA. The deduced IGF-I protein contained 181 amino acids (aa) and consisted of a signal peptide of 44 aa, a B domain of 29 aa, a C domain of 10 aa, an A domain of 21 aa, a D domain of 8 aa, and an E domain of 69 aa (Fig. 1) .
Tissue expression of IGF-I mRNA
By the use of primers in the C and E domains of tilapia, IGF-I in RT-PCR IGF-I gene transcripts were obtained in all organs examined, i.e. liver, pancreas, gut, head kidney, kidney, ovary, testis, gill, eye, and brain. Two amplification products (ϳ500 and ϳ200 bp) were detected, but the PCR product of the expected size (ϳ200 bp) occurred in all organs studied ( Fig. 2A) . By Southern blotting of the DNA and hybridization with an IGF-I specific RNA probe, the approximately 200-bp product was verified. (Fig. 2B) .
Immunohistochemical localization
In liver, no IGF-I-immunoreactive (-IR) cells could be identified for certain. In pancreas, IGF-I immunoreactivity was exclusively confined to the islets, where it was present in somatostatin-IR cells only (Fig. 3, A and B) . In all portions of the gastrointestinal tract, IGF-I-IR endocrine cells (Fig. 3C (Fig. 3D) , which in part seemed to divide. In addition, several cells in the gill epithelium, probably chloride cells, exhibited IGF-immunoreactivity (Fig. 3E) . In the kidney, numerous IGF-I-IR cells were located in the epithelium of proximal tubules (Fig. 3F) . In the head kidney, IGF-I immunoreactivity was detected in interrenal cells, as identified by their specific location and their failure to react with antisera against TH (Fig. 4, A and B) . In the ovary, IGF-I immunoreactivity was occasionally located in granulosa cells around developing oocytes (Fig. 5A ) and constantly around mature (Fig. 5B) oocytes. In the male gonad, IGF-I-IR Sertoli cells and spermatocytes were present (Fig. 5C ). IGF-I-IR neurons were detected at all levels of the brain. In all individuals studied, a varying number of Purkinje perikarya and/or dendrites (Fig. 5D ) in the cerebellum exhibited IGF-I immunoreactivity. However, both frequency and distribution patterns of IGF-I-IR neurons in other areas (Fig. 5E ) showed pronounced variation among the different individuals. In the retina, IGF-I immunoreactivity occurred in receptor and bipolar neurons and in axons of the ganglionic cells (Fig. 5F ). 
Discussion
An 181-aa spanning IGF-I translation product was identified from liver of O. mossambicus. As is typical of the IGFs, it contains a signal peptide and B, C, A, D, and E domains and shows six cysteine residues (Cys B6 , Cys B18 , Cys A6 , Cys A7 , Cys A11 , and Cys
A20
) responsible for maintenance of tertiary structure. At the aa level, tilapia prepro-IGF-I shows 84,4% homology to prepro-IGF-I of S. aurata (26) and 77.3% homology to O. kisutch (3, 4) , but only 44% to human (1). The homologies of tilapia A (90 -95%) and B (86 -97%) domains (Table 1) , however, are remarkably high compared with those of salmonids, S. aurata, and humans, indicating a particularly conservative phylogeny. This result is in accordance to the main physiological impact of IGF-I A and B domains as established in mammals (1) .
The predicted aa sequences of mature IGF-I are identical in all salmonids studied (19) . Compared with their C domains (3-6), that of O. mossambicus is truncated and lacks the two polar aa His C10 and Asn C12 , as also described for Sparus aurata (26) , another member of the perciforms. Thus, the length and polarity of the last four aa residues of tilapia IGF-I C domain resemble the C domain of mammalian IGF-II (1). As for human IGF-I, the C domain plays a significant role in receptor binding affinity (27) , the truncated C domains in O. mossambicus and S. aurata may affect differences in tertiary structure and biological activity.
In contrast to the clear expression of IGF-I mRNA in tilapia liver, no IGF-I-IR liver cells could be identified for certain. Similarly, only low or no IGF-I immunoreactivity was localized in rat liver, but pretreatment with colchicine significantly increased cytoplasmic IGF-I immunoreactivity (28) . Therefore, in tilapia liver, IGF-I is probably rapidly released into the circulation after synthesis, as has been presumed for mammals (28) .
IGF-I mRNA was expressed in both portions of the tilapia gastroentero-pancreatic system. The expression of IGF-I mRNA in pancreas and the correlated presence of IGF-I-IR in islet cells agree with previous immunohistochemical localizations of IGF-I in islet cells of other teleosts (21) (22) (23) and the detection of IGF-I mRNA in salmonid principal islet (19) . The early appearance of IGF-I in islets during fish development (23) suggests important biological functions of isletderived IGF-I. On the one hand, IGF-I derived from the tilapia somatostatin cells may be a paracrine regulator of insulin secretion from the B cells, as is likely in mammals (29) . On the other hand, considerable amounts of sulfation activity have been determined in eel pancreas that were unaffected by hypophysectomy (30) . In goby, 35 SO 4 incorporation in cartilage was significantly reduced after isletectomy, but hepatic GH binding was unchanged (12, 31) . Based on these experiments, it has been assumed that insulin plays the crucial role and interacts with GH in the regulation of hepatic IGF-I production in teleosts (12, 31) . Although mammalian proinsulin stimulated 35 SO 4 incorporation in salmonid cartilage (32) , the presence of IGF-I in teleost islets may indicate that the observed effects (12, 30, 31) are directly caused by islet-derived IGF-I. Thus, islet-derived IGF-I may be involved in fish growth-promoting processes as an endocrine hormone.
The presence of IGF-I at the gene and peptide levels in tilapia gut is consistent with the localization of IGF-I immunoreactivity in entero-endocrine cells of other bony fish (21, 23) and the determination of IGF-I mRNA in salmonid intestine (20, 33) . Although in tilapia islets, IGF-I immunoreactivity occurred in somatostatin-IR cells as found in other bony fish (22, 23) , the IGF-I-IR entero-endocrine cells did not react with any antiserum against the classical islet hormones. Furthermore, in contrast to the IGF-I-IR islet cells, the intestinal IGF-I-IR cells showed remarkable interindividual variation in frequency and distribution. The physiological meaning of these observations is as yet unclear. However, it is tempting to speculate that IGF-I released from mucosal cells may exert paracrine effects in response to varying local demands in contrast to the above-suggested, mainly endocrine effects of islet-derived IGF-I. This hypothesis is supported by studies in the pig, in which the amounts of IGF-I immunoreactivity and type 1 receptors coincide with villous growth and maturation (34) . As in addition to gill and kidney, gut is a major osmoregulatory organ in fish (12) , an involvement of the IGF-IR mucosal cells in osmoregulation is also conceivable.
The expression of IGF-I mRNA in tilapia gill and kidney is consistent with similar results obtained in salmonids (17, 20, 33) and, partly, Sparus aurata (26) . GH and IGF-I significantly improved the ability of rainbow trout to maintain serum osmolarity and sodium levels after transfer to seawater; the effect of IGF-I is greater than that of GH (13) . The levels of IGF-I mRNA in salmonid gill and kidney notably increased after injection of GH; transfer to seawater did not alter the IGF-I mRNA levels in liver, but did so in gill and kidney (17) . Based on these experiments, the hypothesis has been raised that in gill and kidney, IGF-I may function as an autocrine/paracrine factor in osmoregulation (17) . The IGF-IR chloride cells of the gill epithelium shown in the present study are probably the production and release sites for the assumed paracrine effects of IGF-I on osmoregulation in teleost gill. IGF-I seems to exert its osmoregulatory effects directly, as in in vitro preparations of coho salmon gill, recombinant bovine IGF-I stimulated Na ϩ ,K ϩ -adenosine triphosphatase (35) . Nothing is yet known about the possible effects of IGF-I on teleost kidney function. However, our data demonstrating cells of the proximal tubule as the likely sites of IGF-I production indicate that IGF-I in teleost kidney may be involved in several parameters of renal function, as is likely in mammals (36) .
A subpopulation of probably proliferating chondrocytes in the gill filaments also showed IGF-I immunoreactivity. For mammals, the presence of IGF-I in chondrocytes is still under discussion. The expression of IGF-II mRNA has been reported for murine chondrocytes at any stage of development, whereas no IGF-I mRNA could be detected (37) . In contrast, IGF-I immunoreactivity has been localized in proliferating rat chondrocytes (28) , which also express IGF-I mRNA (38) . Although no data were obtained on IGF-II in tilapia cartilage, our results strongly suggest that the observed effects of GH on fish cartilage that are probably mediated by IGF-I (12, 13, 30, 31) under physiological conditions are caused by IGF-I derived from local chondrocytes.
No IGF-I transcripts could be detected in salmonid head kidney (17) . The present study, in contrast, demonstrates the expression of IGF-I mRNA in tilapia head kidney and identifies interrenal cells as the likely source of IGF-I. Poor and mostly negative evidence has been presented on IGF-I in mammalian adrenal cortex (28, 39, 40) . Thus, the presence of IGF-I in interrenal cells may be peculiar to bony fish. An involvement of locally produced IGF-I in the regulation of steroid production has been postulated for mammalian gonads (41) . Although the present study gives the first evidence for the presence of IGF-I in fish interrenal cells, we suggest that IGF-I derived from tilapia interrenal cells may be involved in the local regulation of steroidogenesis.
The expression of IGF-I mRNA in tilapia brain is in agreement with similar results obtained in salmonids (18, 20, 33) and catfish (42) and by the identification of IGF-I receptors in the brain of Cottus scorpius (43) . Remarkably few immunohistochemical localizations of IGF-I have been presented in the central nervous system (CNS). These deal with protochordates and mammals and, thus, indicate that IGF-I in the CNS has a long phylogenetic history. In protochordates, neurons throughout the CNS contained IGF-I immunoreactivity (44) . In the developing rat cerebellum, IGF-I immunoreactivity was localized in neurons and glial cells (45) , and in adult rat brain, IGF-I-IR neurons, especially Purkinje cells, were observed after colchicine treatment (28) . In correspondence, tilapia also exhibited IGF-I-immunoreactivity most pronounced in the cerebellum, but additional IGF-IR neurons were present throughout the brain. The overall and in part varying distribution pattern resembles the expression of IGF-I mRNA at all levels of rat brain (46, 47) and, thus, argues against a neurotransmitter or modulator function of IGF-I. Rather, IGF-I in adult tilapia brain may support the survival of neurons and glial cells, as has been assumed for mammals (47) .
The present study also shows that IGF-I mRNA is expressed in tilapia eye and localizes IGF-I immunoreactivity in retinal receptors and neurons. Recently, expression of IGF-I mRNA has been reported for rat (48) and the cichlid fish, Haplochromis burtoni (49) . The distribution pattern of IGF-I immunoreactivity in tilapia retina resembles that of IGF-I mRNA in both species. IGF-I in neuronal cells of the adult tilapia retina may serve as a maintenance factor, whereas for the receptor cells, an additional involvement of IGF-I in regeneration is conceivable (49) .
In both female and male gonads of tilapia, IGF-I mRNA expression was achieved. The presence of IGF-I mRNA in ovary (18, 20, 33) and testis (20, 50) is supported by results obtained in salmonids. In the ovary, our peptide localization revealed that IGF-I immunoreactivity occurs in granulosa cells of developing and mature oocytes, similar to that described in mammals (28) . A season-dependent IGF-I binding that reached its maximum at the end of prespawning has been observed in carp ovaries (51) , and IGF-I has been shown to induce final oocyte maturation in red seabream in vitro (52) . Thus, in fish, an intraovarian IGF-I system may be involved in the autocrine/paracrine regulation of follicular growth and oocyte maturation. In isolated salmonid spermatogenic and Sertoli cells, the expression of IGF-I has been shown (50) . These observations are consistent with those obtained in tilapia, where IGF-I immunoreactivity also occurred in Sertoli cells and spermatocytes. As IGF-I receptors also occur in salmonid testis (50) , future research may show that local IGF-I plays an important physiological role in several parameters of fish testicular function, as is likely in mammals (41) .
In summary, the presence of IGF-I transcripts in many organs of tilapia supports and extends results obtained in salmonids indicating that extrahepatic IGF-I systems are present at the phylogenetic level of bony fish. In combination with the physiological data available, the present identification of parenchymal cells as potential sites of IGF-I production indicates that local IGF-I systems are involved in the autocrine/paracrine regulation of organ-specific functions in fish. Therefore, both the liver-derived, i.e. endocrine, and autocrine/paracrine organ-specific actions of IGF-I as established in mammals seem to have a long phylogenetic history. This is also stressed by the very conservative evolution of the functionally significant A and B domains.
